A method, RARE-seq, for sensitive detection of cell-free RNAs in blood is demonstrated to have diverse clinical applications including diagnosing and characterizing human cancers, and tracking response to RNA therapeutics.
- Monica C. Nesselbush
- Bogdan A. Luca
- Maximilian Diehn